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ABSTRACT 
 
ICAM-1 release during sepsis is perceived to be related to brain injury. Whereas S100β has 
been known as one of brain injury markers. To measure the mean value of ICAM-1, S100β, to 
find a correlation between ICAM-1 and Glasgow Coma Scale (GCS), between S100β and GCS, 
also ICAM-1 and S100β. An analytical cross-sectional study in 34 sepsis children, measurement 
of ICAM-1, and S100β plasma levels within days 1 and 3 since diagnosis of sepsis. Median 
level of ICAM-1 day one 548,1 (158,6 – 1256,1) ng/mL and day three 596,5 (185,5 – 1264,5) 
ng/mL (p=0,164). S100β median is significantly higher in severe than mild sepsis (p=0,008 
dan p=0,021). On third day S100β was negatively related to GCS (r= - 0,452; p=0,003). The 
correlation observed between ICAM-1 and S100β on day one was r=0,146 (p=0,409) while on 
third day was r=0,184 (p=0,298). The prevalence of encephalopathy sepsis is 5.9%, Median 
ICAM-1 is higher on day three. The Median of S100β is higher in severe than mild sepsis. There 
is no correlation between ICAM-1 and GCS in both sepsis. There was a negative correlation 
between S100β and GCS on 3rd day of sepsis. No correlation between ICAM-1 and S100β on 
both measurement days. 
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INTRODUCTION 
Sepsis is still a major health problem in 
children and adults, nearly 50% of cases end 
in death.1 The highest incidence of sepsis 
occurs in infants (5.16 per 1000) and 
decreases dramatically in older children (0.20 
per 1000 in children aged 10-14 years).2 
Based on data from the Department of 
Pediatrics RSCM between 2011-2012 
recorded the number of pediatric patients 
treated with a diagnosis of sepsis as many as 
90 children, and from January 2013 to 
October 2013 there were 21 children.3   
The infection causes the release of 
inflammatory mediators such as tumor 
necrosis factor-alpha (TNF-α), interleukin-1 
(IL-1), gamma interferon (IFN-γ), which 
activates cellular adherence molecule release 
such as E-selectin, ICAM-1 and VCAM -1. 
These molecules will affect the attachment of 
neutrophils to cerebral vascular endothelial 
cells so that the blood-brain barrier 
permeability increases, and allows the 
mobilization of intra-vascular inflammatory 
cells into brain tissue.4 Blood-brain barrier 
injury associated with endothelial 
dysfunction which can be identified by an 
elevated level of soluble adhesion molecules 
(ICAM-1, VCAM, and E-selectin).5 
Disorders of the blood-brain barrier will 
cause brain hypoxia and a series of changes 
that encourage apoptosis due to necrosis of 
brain cells.4,6  
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Research by Apostolou et al. showed that 
serum ICAM-1 values can be used to detect 
sepsis in both full-term neonates and 
premature neonates as an immune system 
response to inflammatory stimuli. Serum 
ICAM-1 values increase first (on the first 
day) compared to CRP values, so serum 
ICAM-1 measurements can be useful for 
early detection of sepsis in neonates 
suspected of having an infection, so that 
antibiotic administration can begin 
immediately and improve outcome.7 
S100β is an astrocyte protein that is 
responsible for intracellular calcium 
homeostasis. Several previous studies have 
shown that brain cell damage is characterized 
by an increase in serum S100β levels.4,8,9 
S100β can be used to assess the presence of 
hypoxia in the central nervous system even 
though this opinion is still debated.6,8,10 
Until now the mechanism of brain 
damage due to sepsis is still unclear. One way 
to find out this mechanism is by examining 
VCAM-1 and ICAM-1 as markers of 
endothelial activation due to inflammation 
and S100β as markers of brain cell damage.  
This study aims to determine the laboratory 
picture and the relationship between ICAM-
1, S100β and Glasgow Coma Scale (GCS) in 
sepsis patients. 
 
MATERIAL AND METHODS 
  This research is a cross-sectional analytic 
descriptive study of blood levels of ICAM-1 
and S100-β in children with sepsis, which is 
measured on the first and third days of the 
diagnosis of sepsis. The collection of research 
subjects was carried out after passing the 
ethical review from the Medical/Health 
Research Ethics Committee of RSCM FKUI. 
The study was conducted at the Department 
of Child Health Sciences RSCM FKUI and 
Tangerang District Hospital. The study was 
conducted from April 2013 to October 2013. 
Subjects were children aged over 1 month - 
18 years with sepsis or suspected sepsis who 
were treated at the Department of Pediatrics 
FKUI RSCM and Tangerang District 
Hospital during April 2013-October 2013. 
Determination of sepsis accordingly with 
sepsis criteria based on the International 
Consensus of Pediatric Sepsis in 2002. 
Confirmation of infection is done by 
increasing levels of procalcitonin or CRP 
biomarkers, and or positive cultures (blood, 
urine, body fluids, and fungi). Exclusion 
criteria included meningitis, encephalitis, 
cerebral abscesses, cerebral tumors, head 
injuries, lung tumors, cardiac abnormalities, 
post-cardiac surgery who received therapy, 
and did not get the approval of a parent or 
guardian. Every pediatric patient with sepsis 
or suspected sepsis who met the inclusion 
criteria was asked for a research permission 
from the parent or guardian (informed 
consent). Blood samples were taken as much 
as 3 ml of frozen blood, carried out twice to 
examine ICAM-1 and S100-β biomarkers, 
namely the first day and the third day since 
the diagnosis of sepsis. At the end of the 
study period all samples were tested together 
for ICAM-1 and S100-β tests. ICAM-1 
measurements used the Human sICAM-
1/CD54 Immunoassay (R&D Systems, Inc.) 
reagentia test with the ELISA sandwich 
method. Measurement of S100β levels using 
a reagentia test from Nexus DxTMS-100 
(Nanogen Inc., San Diego, CA) with the 
ELISA sandwich method. The level of 
consciousness in all enrolled patients was 
evaluated by the Glasgow Coma Scale (GCS) 
on days 1 and 3. GCS profiles of days 1 and 
3 were tested by the Kolmogorov-Smirnov 
test. The difference in mean ICAM-1 values 
and S100β days 1 and 3 sepsis were tested 
with the Wilcoxon test. Differences in mean 
values of ICAM-1 and S100β based on the 
degree of sepsis were tested by the Mann-
Whitney Test. All test results were 
statistically significant if p <0.05. The 
correlation test used was the Spearman 
correlation test and was statistically 
significant when p <0.05. 
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RESULTS 
During the study period, 41 children with 
sepsis aged over 1 month - 18 years in the 
Department of Pediatrics FKUI RSCM and 
Tangerang District Hospital met the inclusion 
criteria. Six subjects were excluded from the 
study because blood samples on the third day 
of sepsis could not be obtained. A total of 34 
subjects were included in the study. Sixteen 
subjects were new cases in pediatric EDs, 7 
subjects were treated in PICU, and 11 
subjects were patients treated in class III 
wards of children in RSCM and Tangerang 
District Hospital (Figure 1).
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Subjects consisted of 21 boys and 13 girls 
with an age range above 1 month - 18 years. 
Most subjects aged over 1 month - 1 year 
(53%), and pre-school age (20%. Most 
common respiratory and gastrointestinal 
infections, in the form of pneumonia (26%) 
and diarrhea both acute and persistent 
diarrhea (26 %) Based on the degree of 
sepsis, 20 subjects (59%) with mild sepsis 
and 14 subjects with severe sepsis, seven 
patients with severe sepsis need mechanical 
ventilation and sedation (21%) and 11 
subjects (32%) received inotropic drugs due 
to septic shock. During this study, 5 subjects 
died during the treatment period (Table 1)
41 subject (age above 1 month -18 
year) with sepsis 
34 subject under study 
4 subject: died on second day sepsis  
1 subject: Blood sample lysis and 
reject for retake 
1 subject: forced home on the3rd 
day sepsis 
 
Blood sample ICAM-1 dan S100-β  
24 hour I diagnosis with sepsis 
34 subjects 
Blood sample ICAM-1 dan S100-β  
day-3 diagnosis with sepsis 
34 subjects 
exclude 
Figure 1. Research Subject 
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Table 1. Subject Charateristic 
Characteristic Total (n=34) 
Gender 
          Man 
          Girl 
Age [(median, range) month] * 
Age group 
          Age> 1 month - 1 year 
          Pre-school age 
          School age 
          Teenagers - young adults 
Nutritional status 
          Good nutrition 
          Malnutrition 
          Malnutrition 
          Obesity 
Infection Focus 
          Pneumonia 
          Diarrhea (acute / persistent) 
          Pneumonia + Diarrhea 
          Pneumonia + UTI 
          Diarrhea + UTI 
          Peritonitis 
          Pancreatic abscess 
          Acute appendicitis with perforation 
          Not known 
Basic disease 
          Postoperatively 
          Tumor / malignancy 
          Tuberculosis (TB) 
          Thalassemia 
          Without basic disease 
Sepsis degree 
          Sepsis without organ dysfunction (mild) 
          Sepsis with organ dysfunction / (severe) sepsis shock 
Ventilator 
          Without ventilator 
          With a ventilator 
Inotropic 
          Without inotropic 
          With inotropic 
Sedation 
          Without sedation 
          With sedation 
Exodus 
          Life 
          Died 
 
21 (62%) 
13 (38%) 
21 (2 – 201) 
 
18 (53%) 
7 (20%) 
5 (15%) 
4 (12%) 
 
10 (29%) 
17 (50%) 
6 (18%) 
1 (3%) 
 
9 (26%) 
9 (26%) 
4 (12%) 
3 (9%) 
1 (3%) 
5 (15%) 
1 (3%) 
1 (3%) 
1 (3%) 
 
4 (12%) 
3 (9%) 
3 (9%) 
1 (3%) 
23 (67%) 
 
20 (59%) 
14 (41%) 
 
27 (79%) 
7 (21%)  
 
23 (68%) 
11 (32%) 
 
27 (79%) 
7 (21%) 
 
29 (85%) 
5 (15%) 
Data presented in proportion (%), median (minimum - maximum) *
 
Examination of blood cultures, growing 
bacteria in isolates 5 subjects consisting of 
gram-negative bacteria containing LPS 
(Acinetobacter lwoffii and Acinetobacter 
baumanii) and gram-positive bacteria 
containing LTA (Enterococcus and 
Staphylococcus sp). Urine culture grew on 10 
isolates from 5 subjects and the most species 
were E. coli (4 isolates and Klebsiella 
pneumonia (3 isolates)) both of which were 
gram-negative bacteria. Sputum culture grew 
on 4 subjects, including Klebsiella 
pneumonia in 3 isolates, Pseudomonas 
aeruginosa 2 isolates, and 1 isolate 
Acinetobacter baumanii. Culture of ascites 
and fecal fluids grew respectively in 2 
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subjects (Enterococcus and Pseudomonas 
aeruginosa). 
GCS assessment on day I, found 24 
subjects with mild awareness disorders and 6 
subjects with moderate awareness disorders, 
while 4 subjects were difficult to assess 
because using mechanical ventilation and 
getting sedation drugs. Two of the 6 subjects 
were diagnosed as septic encephalopathy 
with GCS scores of 9 and 11 (5.9%), and one 
of the subjects was accompanied by 
generalized seizures. On the third day, the 
GCS of the study subjects were reassessed, 2 
subjects who initially had mild awareness 
disorder and one subject with moderate 
awareness disorder eventually needed help 
with mechanical ventilation and sedation. 
Three subjects experienced a decrease in 
clinical condition and quality of 
consciousness namely GCS score 15 to 13. 
Subjects who did not experience changes in 
GCS score on the third day were 12 subjects 
and 3 subjects continued to use a ventilator. 
Thirteen other subjects experienced an 
increase in GCS scores and clinical 
improvement, including 1 subject with 
mechanical ventilation on the third day 
breathing without assistance  (Table 2). 
 
Table 2. Conscious Disorders Based on First and Third Day GCS 
Concious Disorders Day first 
(n=34) 
Day third 
(n=34) 
Mild (GCS 13 – 15) 
Intermediate (GCS 9 – 12) 
Severe (GCS 3 – 8) 
Difficult to rated# 
 24 (70,6%) 
6 (17,6%) 
- 
4 (11,8%) 
28 (82,4%) 
- 
- 
6 (17,6%) 
#  subjects used mechanical ventilation and sedation
Based on the degree of sepsis, as many as 20 
subjects included in the mild sepsis group and 
14 subjects were severe sepsis. On the first 
day of GCS assessment, the mild sepsis group 
mostly experienced mild awareness disorder 
and only 1 subject with moderate awareness 
disorder. In contrast, the severe sepsis group, 
on the other hand, experienced mild to 
moderate impaired consciousness, and 4 
subjects used mechanical ventilation and 
sedation so GCS was difficult to assess. 
However, based on the comparative test with 
the Kolmogorov-Smirnov test there was no 
correlation between the degree of sepsis and 
the degree of disturbance of consciousness 
based on GCS (p = 0.39). On the third day of 
GCS assessment, the number of subjects with 
mild impaired consciousness in the mild 
sepsis group increased. In the group of severe 
sepsis found an improvement in the quality of 
consciousness that is 8 subjects with mild 
awareness disorders, but 2 subjects who 
initially had mild awareness disorders and 1 
subject with moderate awareness disorders 
eventually needed mechanical ventilation and 
sedation.   
ICAM-1 levels were found to be 
increased in almost all subjects except 1 
subject whose value was below normal. 
ICAM-1 data obtained in this study do not 
have a normal distribution, so the average 
value displayed is the median value 
(minimum - maximum). The mean value on 
the first day of sepsis was 548.1 (158.6 - 
1256.1) ng / mL and on the third day of sepsis 
596.5 (185.5 - 1264.5) ng / mL, no significant 
difference was found between the first day 
and third (p = 0.16). Likewise, the mean value 
of ICAM-1 based on the degree of sepsis, on 
the first and third days of sepsis, did not show 
statistically significant differences (Figure 2).
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Figure 2. The mean value of ICAM-1 is based on the degree of sepsis 
 
The median value of ICAM-1, day I sepsis in the mild and severe sepsis group was 554.1 (158.6 - 1256) ng / mL 
and 594.4 (290.2 - 1067.8) ng / mL (p = 0, 94). The median value of day III sepsis, mild and severe sepsis group 
was 579.5 (185.8 - 1264.5) ng / mL and 687.4 (335.0 - 1258.5) ng / mL (p = 0.94) . 
 
On the first day of sepsis, S100β levels 
above normal were found in 6 severe sepsis 
subjects (4/6 with septic shock) and 2 mild 
sepsis subjects. On the third day of sepsis, 7 
severe sepsis subjects (4/7 with septic shock) 
and 2 mild sepsis subjects had above normal 
S100β levels. The mean value of S100β on 
day I sepsis was 0.085 (0.001 - 0.142) ng / 
mL, while the third day was 0.006 (0.001 - 
0.137) ng / mL. When compared to the mean 
value of S100β on days I and III, there was no 
significant difference (p = 0.936). 
Based on the degree of sepsis, the level 
of S100β day I in the mild sepsis group had 
an average value of 0.0035 (0.001 - 0.08) ng 
/ mL. This result was significantly different 
from the severe sepsis group which had a 
mean value of 0.021 (0.001 - 0.142) ng / mL, 
with p = 0.008. Similarly, the mean value of 
S100β on day III in the severe sepsis group 
was higher than in mild sepsis (p = 0.020) 
(Figure3).
 
Figure 3. S100-B values are based on the degree of sepsis 
 
The mean value of S100β day I in the mild and severe sepsis group was 0.0035 (0.001 - 0.08) ng / mL and 0.021 
(0.001 - 0.142) ng / mL (p = 0.008). The mean value of S100β on day III, the mild and severe sepsis group was 
0.004 (0.001 - 0.065) ng / mL and 0.032 (0.001 - 0.137) ng / mL (p = 0.020). 
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Correlation between ICAM-1 and GCS 
scores was performed by the Spearman 
correlation test. The results of the test 
obtained a correlation that was directly 
proportional (r = 0.190) between ICAM-1 
levels and GCS scores on the first day but 
did not reach statistical significance (p = 
0.314). The correlation test between ICAM-
1 levels and GCS day III scores showed a 
negative correlation and was not 
statistically significant (r = - 0.183; p = 
0.352). 
Correlation between S100β levels and 
GCS scores day I was tested by the 
Spearman correlation test, showing a 
negative correlation (r = - 0.161) but 
statistically not significant (p = 0.394).  
Correlation test between levels of 
S100β with GCS values of day III found a 
negative correlation (r = - 0.40) which was 
statistically significant p = 0.035. 
ICAM-1 and S100β correlation tests were 
performed with the Spearman correlation 
test, obtained a correlation that was directly 
proportional between ICAM-1 day I levels 
with S100β day I (r = 0.146; p = 0.409). 
Correlation between ICAM-1 day III levels 
and S100β day III, the correlation was 
directly proportional but not statistically 
significant (r = 0.184) with p = 0.298. 
 
DISCUSSION 
The highest age distribution of sepsis 
patients in this study is the age group above 
1 month to 1 year, more men than women, 
and most (50%) with poor nutritional status. 
These results are consistent with research 
conducted in the United States in 2001 and 
2003, that the highest incidence of sepsis 
was found in children under 1 year 
(5.6/1000) and decreased dramatically in 
the age group 10-14 years (0.2/1000). The 
high incidence of sepsis in children under 1 
year is said to be related to the host's 
immune system response to infection.11 The 
incidence of sepsis in boys (55%) is higher 
than in girls.2,12 The focus of infection as the 
most common cause of sepsis is respiratory 
infections (pneumonia) and gastrointestinal 
infections. Pathogenic germs found from 
blood culture results are gram-positive (3/5) 
and gram-negative (2/5) germs. Based on 
the study of Angus et al from 192,980 cases 
of severe sepsis, 44% of the causes were 
respiratory infections and more than half of 
cases were found to be gram-positive 
germs.12  In this study found 5 patients died 
during the treatment period (15%), slightly 
higher than the study conducted by Watson 
et al namely from 9,675 pediatric patients 
with severe sepsis, as many as 993 patients 
(10.3%) of them died during the treatment 
period.2  
The majority of sepsis patients in this 
study experienced mild or no conscious 
disturbance on both first and third day 
sepsis. Classification of consciousness 
disorders in this study include mild 
awareness disorders (GCS 13-15), 
moderate (GCS 9-12), and severe (3-8).13 
As a result, subjects without disturbance of 
consciousness are included in the group of 
mildly impaired consciousness. On the first 
day of sepsis, all subjects from the severe 
sepsis group experienced a disturbance of 
consciousness, whereas in the mild sepsis 
group there were 12 subjects without 
disturbance of consciousness (GCS = 15). 
Moderate awareness disorders are more 
common in the severe sepsis group. The 
third day of sepsis, in both groups both mild 
and severe sepsis generally experienced 
clinical improvement and quality of 
consciousness. But in the mild sepsis group, 
2 people experienced a decrease in the 
quality of consciousness that was initially 
fully conscious to become a mild 
disturbance of consciousness, whereas in 
the severe sepsis group 3 subjects 
experienced a decrease in the quality of 
consciousness. In general, 2 subjects (5.9%) 
were found with sepsis encephalopathy 
(GCS score ≤ 11) originating from the 
severe sepsis group. 
ICAM-1 levels in this study increased 
in almost all subjects, both on day I sepsis 
and day III, except for one subject with a 
normal value. The results of this study are 
in accordance with previous studies which 
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stated that ICAM-1 levels in sepsis patients 
were significantly increased when 
compared to controls. The mean value of 
ICAM-1 on days I and III increased even 
though there was no significant difference 
(p = 0.164). Based on the degree of sepsis, 
the mean value of ICAM-1 between the 
mild and severe sepsis groups on both 
sepsis I and III days, also showed no 
statistically significant difference (p = 0.89 
versus p = 0.71). This result might be 
influenced by the size of the study subjects 
that are lacking and measurement of serum 
ICAM-1 levels which were only carried out 
twice less showed an increasing trend in 
accordance with clinical course. 
Research by Bustamante et al on 
adhesion molecules (ICAM-1, VCAM-1, 
and E-selectin) measured on the first, 3rd 
and 7th day of sepsis in 118 patients under 
1 year (88 sepsis patients and 30 patients 
without SIRS and sepsis as controls), 
showed that levels of all adhesion 
molecules increased compared to controls. 
However, no relationship was found 
between the levels of adhesion molecules 
and the degree of sepsis.14  
Researchers did not find a correlation 
between ICAM-1 levels with GCS scores 
on days I and III sepsis in this study, this 
result might be due to the short observation 
time. Previous studies looking for an 
association between ICAM-1 and GCS 
scores in sepsis patients are difficult to find. 
One study by McKeating et al reported that 
serum ICAM-1 values were significantly 
increased at 96 hours of ICU care and there 
was a significant relationship between 
serum ICAM-1 and GCS (p <0.001) in 22 
subjects with brain injury due to trauma. 
After primary brain injury, increased 
expression of ICAM-1 might result in 
secondary brain injury. The change in 
expression of ICAM-1 and L-selectin after 
head injury due to trauma is believed to 
increase the concentration of ICAM-1 
serum and this change may be related to the 
degree of brain damage and neurological 
outcomes.15 
Serum S100β protein levels are 
associated with tissue hypoperfusion, as 
reported by previous studies.8,9,16 In this 
study the mean serum S100β value in the 
severe sepsis group was higher than in mild 
sepsis both on the first and third day of 
sepsis (p = 0.008 and p = 0.20) and most 
subjects with severe sepsis experienced 
sepsis shock (10/14). The highest S100β 
levels were found in this group. Research 
conducted by Routsi et al reports that S100β 
levels increase in critical patients without 
brain damage and support the opinion that 
increased S100β levels may be associated 
with tissue hypoperfusion.7 While research 
by Hsu et al. Concluded that an increase in 
S100β and NSE in serum showed that septic 
shock caused the release of protein 
structures originating from brain cells, and 
this release indicated neurological damage.8 
In this study, the mean value of S100β 
on the first day of sepsis was 0.085 (0.001 - 
0.142) ng / mL and the third day was 0.006 
(0.001 - 0.137) ng / mL. Whereas in 
previous studies stating that S100β levels 
increase every day in sepsis shock patients. 
The difference in the results of this study 
may be caused by several things, among 
others: 1) measurement of S100β levels was 
carried out on the first day (first 24 hours) 
of patients diagnosed with sepsis and the 
third day, whereas research by Hsu8 and 
Nguyen16 take measurements on the first 
day when a patient experiences sepsis shock 
or while being treated at the ICU, 2) the 
inclusion criteria of this study are pediatric 
patients with both mild and severe sepsis, 
unlike most other studies that use only 
severe sepsis patients. The difference in 
sampling time for the S100β examination 
according to researchers influenced studies, 
such as the study conducted by Towned et 
al., Found that the elimination half-life of 
S100β after being released into circulation 
was 97 minutes (95% CI 75 - 136 minutes) 
in patients who suffered brain injury due to 
trauma.17 This finding supports previous 
research by Jackson et al. which states that 
S100β levels in circulation rapidly 
decrease, the half-life found in the form of 
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a median value of 198 minutes, so as to 
assess S100β levels must be done as soon as 
possible from the time of the trauma to 
obtain maximum information. S100β 
examination is recommended to be taken 
periodically (every 4 hours) to detect the 
increase before the level of serum 
decreases.18  
The correlation between S100β and 
GCS levels on day I was not found and was 
not statistically significant (Spearman 
correlation test, r = -0.161; p 0.394), 
whereas on day III sepsis found a 
significant inverse correlation (Spearman 
correlation test, r = -0.40; p = 0.035). It is 
undeniable that in this study several 
subjects could not be assessed for impaired 
consciousness with GCS because it was 
under the influence of sedation and 
certainly affected the results of the study 
because the number of subjects analyzed 
was reduced. Researchers found little 
literature looking for a direct correlation 
between S100β and GCS levels in sepsis 
patients, including studies conducted by 
Piazza and Nguyen. Piazza et al found that 
S100β had no correlation with GCS scores 
(r = 0.082). However, this study only 
involved 21 subjects with severe sepsis, so 
it was difficult to find any correlation 
between the two.19 Nguyen et al studied 170 
adult patients with severe sepsis and septic 
shock, and 50 patients who underwent heart 
bypass surgery without complications as a 
control. This study found an insignificant 
negative correlation between GCS scores 
with serum S100β. They concluded that 
S100β reflected more severe sepsis 
encephalopathy than NSE and GCS.16 
However, another study by El-Deen et al on 
40 patients with head injury due to trauma, 
found a correlation that was inversely 
correlated between serum S100β and GCS 
which was statistically significant (r = -
0.452; p = 0.003). 20 
This study is the first to look for 
correlations between ICAM-1 and S100β 
activation in pediatric patients with sepsis. 
Many studies report that ICAM-1 and 
S100β levels are increased in patients with 
severe sepsis and sepsis shock, but further 
analysis conducted to find the relationship 
between the two in this study, did not show 
any correlation (r = 0.146 with p = 0.409 
and r = 0.184 with p = 0.298). Previous 
research has stated that problems found in 
sepsis are a direct result of the excessive 
production of pro-inflammatory molecules. 
Sepsis patients with high TNF-α have a high 
risk of death and the injection of TNF 
molecules in experimental animals results 
in widespread inflammatory processes and 
tissue damage. Inflammatory reactions 
themselves are associated with increased 
blood-brain barrier permeability to 
cytokines and expression of adhesion 
molecules. Inflammatory cytokines (TNF-
α) and IL-1) are also produced by neurons 
and both participate in communication 
between nerves and the immune system.21 
During sepsis shock, there is an increase in 
products released by the body in response to 
sepsis such as cytokines, chemokines and 
other nitric oxide, which may injure brain 
cells and cause the release of protein 
structures in brain cells as a sign of 
neurological injury.8,16 
This research is a descriptive analytic 
study with various unavoidable 
weaknesses. One disadvantage is that 
measurements of S100β and ICAM-1 were 
only performed twice on study subjects, 
namely on the first day of sepsis and on the 
third day the subject was diagnosed. Some 
studies suggest that measurement of 
biomarker levels should see trends with 
serial measurements in line with clinical 
judgment. The prevalence of sepsis 
encephalopathy obtained in this study may 
be lower, because some subjects were 
involved in the effect of sedation so 
evaluating impaired consciousness with 
GCS is difficult to assess. 
 
CONCLUSION 
In this study most of the subjects aged 
over 1 month to 1 year, more boys than 
girls, and the diagnosis of the most common 
causes of sepsis are respiratory infections 
(pneumonia) and gastrointestinal 
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infections. The prevalence of sepsis 
encephalopathy found in this study was 
2/34 subjects (5.9%). The median ICAM-1 
value on the third day of sepsis was higher 
than the median ICAM-1 value on the first 
day of sepsis (595.5 ng/mL versus 548.1 
ng/mL). In this study the median S100β 
value on day I sepsis was 0.085 ng/mL and 
median day III sepsis 0.006 ng/mL. The 
median value of S100β in severe sepsis is 
higher than mild sepsis which is statistically 
significant. There was no correlation 
between ICAM-1 and GCS in either the 
mild or severe sepsis group, nor did ICAM-
1 correlate with GCS on days I and III 
sepsis. There is a negative correlation 
between S100β and GCS score on the third 
day of sepsis. There was no correlation 
between ICAM-1 and S-100β on days I and 
III sepsis. Further research is needed to 
determine the relationship between S100β 
and neurological outcomes due to sepsis in 
pediatric patients. 
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